Suppr超能文献

在植入起搏器之前我们应该进行血管重建吗?

Should we revascularize before implanting a pacemaker?

作者信息

Yesil Murat, Bayata Serdar, Arikan Erdinc, Yilmaz Rustem, Postaci Nursen

机构信息

Department of Cardiology, Ataturk Teaching Hospital, Izmir, Turkey.

出版信息

Clin Cardiol. 2008 Oct;31(10):498-501. doi: 10.1002/clc.20280.

Abstract

BACKGROUND

The effect of coronary revascularization on disappearance of the severe conduction disturbances is still unclear.

HYPOTHESIS

We sought to determine whether revascularization may induce recovery of sinus rhythm in patients with significant coronary artery disease and complete atrioventricular block (AVB).

METHODS

Fifty-three patients who had third-degree AVB and significant coronary artery disease were enrolled. Patients with acute coronary syndromes were excluded. Thirty-three (62%) patients were men and the mean age was 65 +/- 10 y. All patients received a permanent dual-mode, dual-pacing, dual-sensing (DDD) pacemaker. Coronary disease was treated medically in 16 (30%) patients due to patient preference or ineligibility. Thirty-seven (70%) patients underwent a revascularization procedure (coronary artery bypass grafting [CABG]: 16, percutaneous coronary intervention [PCI]: 21 pts). Mean follow-up was 36 +/- 6 mo and patients were evaluated every 3 mo according to their resting electrocardiograms (ECGs) at each visit.

RESULTS

In the medically treated group, 13 (81%) patients still had third-degree AVBs at the end of the follow-up period, while 3 (19%) patients returned to normal sinus rhythm. On the other hand, 27 out of 37 patients (73%) who were revascularized were still in complete AVB, and 10 patients from this group (27%) had returned to normal sinus rhythm. There was no statistically significant difference between the revascularized and medically treated groups in terms of need for a pacemaker.

CONCLUSIONS

Patients who have concomitant severe conduction disturbances and significant coronary disease may well receive a pacemaker before a revascularization procedure. Our data shows that coronary revascularization has little, if any, impact on returning to normal AV conduction.

摘要

背景

冠状动脉血运重建对严重传导障碍消失的影响仍不明确。

假设

我们试图确定血运重建是否可使患有严重冠状动脉疾病和完全性房室传导阻滞(AVB)的患者恢复窦性心律。

方法

纳入53例患有三度AVB和严重冠状动脉疾病的患者。排除急性冠状动脉综合征患者。33例(62%)为男性,平均年龄为65±10岁。所有患者均接受永久性双腔、双起搏、双感知(DDD)起搏器。16例(30%)患者因患者偏好或不符合条件而接受药物治疗冠状动脉疾病。37例(70%)患者接受了血运重建手术(冠状动脉旁路移植术[CABG]:16例,经皮冠状动脉介入治疗[PCI]:21例)。平均随访时间为36±6个月,每次随访时根据静息心电图(ECG)每3个月对患者进行评估。

结果

在药物治疗组中,13例(81%)患者在随访期末仍有三度AVB,而3例(19%)患者恢复为正常窦性心律。另一方面,37例接受血运重建的患者中有27例(73%)仍处于完全性AVB,该组中有10例患者(27%)恢复为正常窦性心律。血运重建组和药物治疗组在起搏器需求方面无统计学显著差异。

结论

伴有严重传导障碍和严重冠状动脉疾病的患者在血运重建手术前可能适合接受起搏器治疗。我们的数据表明,冠状动脉血运重建对恢复正常房室传导的影响很小(如果有影响的话)。

相似文献

引用本文的文献

3
Resolution of Marked Bradycardia Following Angioplasty.血管成形术后显著心动过缓的缓解
Cureus. 2023 Dec 12;15(12):e50412. doi: 10.7759/cureus.50412. eCollection 2023 Dec.
5
Ischemia Possibly Associated with High Degree Atrioventricular Block.缺血可能与高度房室传导阻滞有关。
Case Rep Cardiol. 2023 Aug 19;2023:6676757. doi: 10.1155/2023/6676757. eCollection 2023.
8
Prevalence of bradyarrhythmias needing pacing in COVID-19.新型冠状病毒肺炎患者缓慢性心律失常及起搏治疗的发生率。
Pacing Clin Electrophysiol. 2021 Aug;44(8):1340-1346. doi: 10.1111/pace.14313. Epub 2021 Jul 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验